FLUDARABINE PHOSPHATE
Generic: FLUDARABINE PHOSPHATE
Actavis PharmaManufacturer
INTRAVENOUSRoute
FLUDARABINE PHOSPHATEActive Substance
2009-02-11Original Approval
FLUDARABINE PHOSPHATE is FDA application ANDA078610, sponsored by ACTAVIS TOTOWA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
OFF LABEL USE
1,437 reports
2
PYREXIA
950 reports
3
FEBRILE NEUTROPENIA
801 reports
4
NEUTROPENIA
594 reports
5
PRODUCT USE IN UNAPPROVED INDICATION
524 reports
6
DRUG INEFFECTIVE
518 reports
7
CYTOKINE RELEASE SYNDROME
509 reports
8
CYTOMEGALOVIRUS INFECTION
462 reports
9
SEPSIS
451 reports
10
PANCYTOPENIA
415 reports